Skip to main content

Inmune Bio, Inc.

INMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001711754

No open-market purchases or sales by Inmune Bio, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Inmune Bio, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
43
+2 vs. Q3 2021
Shares held
2.49M
+543.6K (+28.0%) vs. Q3 2021
Total value
$25.4M
−$12.4M (−32.8%) vs. Q3 2021
New holders
8
17 more added
Sold out
6
12 more reduced

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting INMB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 43 institutions
Q1 2021: 33 institutionsQ2 2021: 41 institutionsQ3 2021: 41 institutionsQ4 2021: 43 institutionsQ1 2022: 34 institutionsQ2 2022: 36 institutionsQ3 2022: 33 institutionsQ4 2022: 34 institutionsQ1 2023: 35 institutionsQ2 2023: 34 institutionsQ3 2023: 37 institutionsQ4 2023: 48 institutionsQ1 2024: 52 institutionsQ2 2024: 57 institutionsQ3 2024: 67 institutionsQ4 2024: 73 institutionsQ1 2025: 82 institutionsQ2 2025: 79 institutionsQ3 2025: 73 institutionsQ4 2025: 74 institutionsQ1 2026: 82 institutionsQ2 2026: 82 institutions
Value heldQ4 2021: $25.4M
Q1 2021: $15.5MQ2 2021: $30.6MQ3 2021: $37.7MQ4 2021: $25.4MQ1 2022: $19.3MQ2 2022: $17.7MQ3 2022: $11.9MQ4 2022: $10.4MQ1 2023: $11.7MQ2 2023: $18.2MQ3 2023: $14.5MQ4 2023: $25.8MQ1 2024: $32.2MQ2 2024: $40.3MQ3 2024: $28.8MQ4 2024: $29.5MQ1 2025: $48.1MQ2 2025: $12.7MQ3 2025: $9.64MQ4 2025: $7.93MQ1 2026: $6.09MQ2 2026: $7.08M
Institutions holding INMB and their total value by quarter
QuarterHoldersValue
Q2 202682$7.08M
Q1 202682$6.09M
Q4 202574$7.93M
Q3 202573$9.64M
Q2 202579$12.7M
Q1 202582$48.1M
Q4 202473$29.5M
Q3 202467$28.8M
Q2 202457$40.3M
Q1 202452$32.2M
Q4 202348$25.8M
Q3 202337$14.5M
Q2 202334$18.2M
Q1 202335$11.7M
Q4 202234$10.4M
Q3 202233$11.9M
Q2 202236$17.7M
Q1 202234$19.3M
Q4 202143$25.4M
Q3 202141$37.7M
Q2 202141$30.6M
Q1 202133$15.5M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Inmune Bio, Inc.; share changes are against Q3 2021.

Institutions holding INMB in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc511,029$5.21M0.00%+62,118+13.8%Added
Morgan Stanley378,487$3.86M0.00%+353,856+1,436.6%Added
BlackRock Inc.233,265$2.38M0.00%+86,836+59.3%Added
ACT Capital Management, LLC230,500$2.35M1.70%−44,500−16.2%Reduced
Millennium Management LLC150,680$1.54M0.00%+27,169+22.0%Added
Geode Capital Management, LLC118,270$1.21M0.00%+28,663+32.0%Added
Janney Montgomery Scott LLC113,914$1.16M0.00%+14,591+14.7%Added
Deutsche Bank AG106,048$1.08M0.00%−80.0%Reduced
Susquehanna International Group, LLP90,578$924.0K0.00%+8,049+9.8%Added
Citadel Advisors LLC67,893$693.0K0.00%+15,201+28.8%Added
Marshall Wace, LLP57,382$585.0K0.00%−7,268−11.2%Reduced
Royal Bank of Canada44,031$449.0K0.00%−82,380−65.2%Reduced
UBS Group AG35,950$367.0K0.00%+5,824+19.3%Added
Advisor Group Holdings, Inc.35,738$364.0K0.00%+23,568+193.7%Added
State Street Corp33,816$345.0K0.00%+6,100+22.0%Added
Group One Trading, L.P.30,827$314.0K0.01%+13,021+73.1%Added
Virtu Financial LLC24,364$249.0K0.03%+24,364New
Jump Financial, LLC21,100$215.0K0.01%+21,100New
Alps Advisors Inc20,650$211.0K0.00%−1,049−4.8%Reduced
Goldman Sachs Group Inc20,053$205.0K0.00%+20,053New
Northern Trust Corp19,905$203.0K0.00%−2,316−10.4%Reduced
Fermata Advisors, LLC17,955$183.0K0.07%+5,125+39.9%Added
Jane Street Group, LLC17,098$175.0K0.00%+17,098New
Walleye Capital LLC17,127$175.0K0.01%+17,127New
Financial Advocates Investment Management15,167$155.0K0.01%−1,500−9.0%Reduced
Susquehanna Fundamental Investments, LLC12,473$127.0K0.00%−4,727−27.5%Reduced
Wells Fargo & Company11,509$118.0K0.00%+8,882+338.1%Added
Dimensional Fund Advisors LP11,052$113.0K0.00%00.0%Unchanged
YorkBridge Wealth Partners, LLC10,369$106.0K0.02%00.0%Unchanged
Westside Investment Management, Inc.7,800$79.0K0.00%+7,800New
Tower Research Capital LLC (TRC)7,306$75.0K0.00%+7,306New
Bank of America Corp3,769$38.0K0.00%+1,970+109.5%Added
Leonteq Securities AG2,800$28.6K0.00%+1,500+115.4%Added
Simplex Trading, LLC2,310$23.0K0.00%−5,056−68.6%Reduced
FNY Investment Advisers, LLC1,100$11.0K0.01%+300+37.5%Added
Migdal Insurance & Financial Holdings Ltd.1,003$10.0K0.00%−605−37.6%Reduced
Valley National Advisers Inc1,000$10.0K0.00%00.0%Unchanged
Covington Capital Management1,000$10.0K0.00%00.0%Unchanged
Asset Dedication, LLC814$8.00K0.00%00.0%Unchanged
High Net Worth Advisory Group LLC500$5.00K0.00%+500New
Federation des caisses Desjardins du Quebec400$4.08K0.00%00.0%Unchanged
Captrust Financial Advisors269$3.00K0.00%−131−32.8%Reduced
IFP Advisors, Inc184$2.00K0.00%−100−35.2%Reduced
Ikarian Capital, LLC0$00.00%−26,632−100.0%Sold out
DG Capital Management, LLC0$00.00%−20,000−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−19,989−100.0%Sold out
Belvedere Trading LLC0$00.00%−16,177−100.0%Sold out
Kelly Financial Services LLC0$00.00%−2,000−100.0%Sold out
Parallel Advisors, LLC0$00.00%−100−100.0%Sold out